Skip to content

Postoperative Analgesia After Low Frequency Electroacupuncture

Postoperative Analgesia After Low Frequency Electroacupuncture as Adjunctive Therapy in Inguinal Hernia Surgery With Abdominal Wall Mesh Reconstruction

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01722253
Acronym
LFE
Enrollment
54
Registered
2012-11-06
Start date
2008-12-31
Completion date
2015-04-30
Last updated
2015-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inguinal Hernia

Keywords

electroacupuncture, acupuncture, pain management

Brief summary

The purpose of this study is to determine whether electroacupuncture is a effective tool to the postoperative analgesia

Detailed description

The electroacupuncture is a known therapeutic modality with particular application to pain. In this study the investigators investigate the effect of electroacupuncture in condition of surgery, which is a particularly painful situation. The investigators will verify the postoperative analgesia, as patients will receive either electroacupuncture or placebo electroacupuncture.

Interventions

PROCEDUREElectroacupuncture

Electrical stimulation device with frequency 2 Hz and 'frequency scanning mode'

Sponsors

Aristotle University Of Thessaloniki
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy male volunteers * 18-75 years old

Exclusion criteria

* bilateral or recurrent hernia * significant cardiovascular, pulmonary, renal, hepatic, neurological disease * psychiatric history * use of opioids until the last month * body mass index greater than 30 * treatment with beta-blockers * aged over 75 * previous experience with acupuncture * hypersensitivity to opioids * pacemaker patient * patients being treated with monoamine oxidase inhibitors and selective serotonin reuptake inhibitors.

Design outcomes

Primary

MeasureTime frameDescription
Monitoring of pain with the Visual Analogue scale within the first 24 hours after surgerywithin the first 24 hours after surgeryMonitoring of pain with the Visual Analogue scale performed preoperatively and at 30, 90 min, 10 hours and 24 hours after surgery

Secondary

MeasureTime frameDescription
Control of anxiety with the State-Trait Anxiety Inventory within 24 hours after surgerywithin the first 24 hours after surgeryThe State-Trait Anxiety Inventory performed preoperatively and at 30, 90 min, 10 hours and 24 hours after surgery

Other

MeasureTime frameDescription
Monitoring of pain with the use of an algometer within the first 24 hours after surgerywithin the first 24 hours after surgeryMonitoring of pain with the use of an algometer performed preoperatively and at 30, 90 min, 10 hours and 24 hours after surgery

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026